State of New Jersey Common Pension Fund D Sells 21,644 Shares of Henry Schein, Inc. (NASDAQ:HSIC)

State of New Jersey Common Pension Fund D lowered its stake in Henry Schein, Inc. (NASDAQ:HSIC) by 32.4% during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 45,209 shares of the company’s stock after selling 21,644 shares during the period. State of New Jersey Common Pension Fund D’s holdings in Henry Schein were worth $2,898,000 as of its most recent SEC filing.

A number of other institutional investors have also recently made changes to their positions in HSIC. KBC Group NV boosted its position in Henry Schein by 163.5% during the 4th quarter. KBC Group NV now owns 521,964 shares of the company’s stock valued at $39,518,000 after buying an additional 323,901 shares during the period. Everett Harris & Co. CA lifted its stake in shares of Henry Schein by 13.9% in the 1st quarter. Everett Harris & Co. CA now owns 119,257 shares of the company’s stock worth $9,006,000 after purchasing an additional 14,580 shares during the period. UniSuper Management Pty Ltd boosted its stake in shares of Henry Schein by 611.8% during the 1st quarter. UniSuper Management Pty Ltd now owns 13,695 shares of the company’s stock worth $1,034,000 after acquiring an additional 11,771 shares during the last quarter. Envestnet Portfolio Solutions Inc. grew its holdings in Henry Schein by 64.2% during the first quarter. Envestnet Portfolio Solutions Inc. now owns 41,558 shares of the company’s stock valued at $3,138,000 after purchasing an additional 16,241 shares during the period. Finally, Pzena Investment Management LLC grew its stake in shares of Henry Schein by 61.4% during the 4th quarter. Pzena Investment Management LLC now owns 809,558 shares of the company’s stock valued at $61,292,000 after acquiring an additional 307,934 shares during the period. Hedge funds and other institutional investors own 96.62% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts have recently issued reports on the company. Barrington Research reduced their target price on Henry Schein from $92.00 to $82.00 and set an “outperform” rating on the stock in a report on Wednesday, August 7th. UBS Group cut their price objective on Henry Schein from $75.00 to $72.00 and set a “neutral” rating on the stock in a research report on Wednesday, August 7th. Evercore ISI decreased their price target on shares of Henry Schein from $72.00 to $70.00 and set an “in-line” rating for the company in a research note on Wednesday, August 7th. JPMorgan Chase & Co. lowered their price target on Henry Schein from $88.00 to $80.00 and set an “overweight” rating for the company in a report on Monday, August 12th. Finally, Robert W. Baird reduced their price objective on Henry Schein from $92.00 to $82.00 and set an “outperform” rating on the stock in a report on Wednesday, August 7th. One research analyst has rated the stock with a sell rating, six have issued a hold rating, five have issued a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Hold” and an average target price of $77.10.

Insider Buying and Selling at Henry Schein

In other news, SVP Lorelei Mcglynn sold 21,035 shares of Henry Schein stock in a transaction that occurred on Friday, September 6th. The shares were sold at an average price of $69.30, for a total transaction of $1,457,725.50. Following the completion of the transaction, the senior vice president now directly owns 71,833 shares of the company’s stock, valued at approximately $4,978,026.90. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. 1.14% of the stock is currently owned by corporate insiders.

Henry Schein Stock Up 1.7 %

HSIC stock opened at $72.46 on Thursday. The company has a market capitalization of $9.28 billion, a P/E ratio of 24.48, a price-to-earnings-growth ratio of 1.88 and a beta of 0.86. Henry Schein, Inc. has a 12 month low of $60.01 and a 12 month high of $82.63. The firm’s fifty day simple moving average is $69.62 and its 200-day simple moving average is $70.41. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.55 and a quick ratio of 0.90.

Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings results on Tuesday, August 6th. The company reported $1.23 EPS for the quarter, beating the consensus estimate of $1.22 by $0.01. The company had revenue of $3.10 billion for the quarter, compared to analyst estimates of $3.27 billion. Henry Schein had a net margin of 2.82% and a return on equity of 13.19%. The firm’s revenue was up .0% on a year-over-year basis. During the same period in the prior year, the company earned $1.31 earnings per share. As a group, equities research analysts forecast that Henry Schein, Inc. will post 4.75 earnings per share for the current year.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.